SCGB2A2 (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:4250, HGNC:7050, MGB1, MIM:605562, NM_002411, NP_002402, PSBP1, SCGB2A2, UGB2, XM_005274005, XP_005274062, secretoglobin family 2A member 2

Omim:OMIM:605562

Id:745d3b6f-529c-52cc-b594-9fc80b34b4e0

Hgnc:HGNC:7050

Entrez:4250

Ensembl:ENSG00000110484

Description:secretoglobin family 2A member 2

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View SCGB2A2's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with SCGB2A2.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using SCGB2A2.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for SCGB2A2.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with SCGB2A2.

Results found

Linked to

	Label	Description
	GSE133927 PTEN p53 Meox1 knockdown BT-549 RNA Small Interfering 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE158969 1 V 0 TRASTUZUMAB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	T70-White-Adipose Consensus Gene Set (Entity type)	A Gene Set from MoTrPAC
	GSE207514 GSE207515 PI3K inhibition 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE207514,GSE207515 1 V 3 ACETYLCYSTEINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE160001 GSE160670 lapatinib SK-BR-3 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216540 fulvestrant 1 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE158969 1 V 2 TRASTUZUMAB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE160001,GSE160670 3 V 2 LAPATINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 ruxolitinib 4 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE133927 PTEN p53 Meox1 knockdown BT-549 RNA Small Interfering 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE158969 1 V 0 TRASTUZUMAB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

T70-White-Adipose Consensus

Gene Set (Entity type)

A Gene Set from MoTrPAC

GSE207514 GSE207515 PI3K inhibition 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE207514,GSE207515 1 V 3 ACETYLCYSTEINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE160001 GSE160670 lapatinib SK-BR-3 3 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE216540 fulvestrant 1 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE158969 1 V 2 TRASTUZUMAB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE160001,GSE160670 3 V 2 LAPATINIB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE193351 ruxolitinib 4 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.